eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications

Abruptio Placentae

Author: Shad H Deering, MD, Clinical Assistant Professor, Department of Obstetrics and Gynecology, University of Washington; Medical Director, Andersen Simulation Center, Madigan Army Medical Center
Contributor Information and Disclosures

Updated: Dec 22, 2008

Introduction

Background

Abruptio placentae is defined as the premature separation of the placenta from the uterus. Patients with abruptio placentae typically present with bleeding, uterine contractions, and fetal distress. A significant cause of third-trimester bleeding associated with both fetal and maternal morbidity and mortality, abruptio placentae must be considered whenever bleeding is encountered in the second half of pregnancy.

Pathophysiology

Hemorrhage into the decidua basalis occurs as the placenta separates from the uterus. Vaginal bleeding usually follows, although the presence of a concealed hemorrhage in which the blood pools behind the placenta is possible.

If the bleeding continues, fetal and maternal distress may develop. Fetal and maternal death may occur if appropriate interventions are not undertaken. The primary cause of placental abruption is usually unknown, but multiple risk factors have been identified.

Frequency

United States

The frequency of abruptio placentae in the United States is approximately 1%, and a severe abruption leading to fetal death occurs in 0.12% of pregnancies (1:830).

Mortality/Morbidity

Maternal or fetal mortality or morbidity may occur.

If an abruption occurs, the risk of perinatal mortality is reported as 119 per 1,000 people in the United States, but this can depend on the extent of the abruption and the gestational age of the fetus. This rate is higher in patients with a significant smoking history. Fetal morbidity is caused by the insult of the abruption itself and by issues related to prematurity when early delivery is required to alleviate maternal or fetal distress.

Currently, placental abruption is responsible for approximately 6% of maternal deaths. Maternal and fetal complications include issues related to (1) cesarean delivery, (2) hemorrhage/coagulopathy, and (3) prematurity, described as follows:

  • Cesarean delivery: Cesarean delivery is often necessary if the patient is far from her delivery date or if significant fetal compromise develops. If significant placental separation is present, the fetal heart rate tracing typically shows evidence of fetal decelerations and even persistent fetal bradycardia. A cesarean delivery may be complicated by infection, additional hemorrhage, the need for transfusion of blood products, injury of the maternal bowel or bladder, and/or hysterectomy for uncontrollable hemorrhage. In rare cases, death occurs.
  • Hemorrhage/coagulopathy: Disseminated intravascular coagulation (DIC) may occur as a sequela of placental abruption. Patients with a placental abruption are at higher risk of developing a coagulopathic state than those with placental previa. The coagulopathy must be corrected to ensure adequate hemostasis in the case of a cesarean delivery.
  • Prematurity: Delivery is required in cases of severe abruption or when significant fetal or maternal distress occurs, even in the setting of profound prematurity. In some cases, immediate delivery is the only option, even before the administration of corticosteroid therapy in these premature infants. All other problems and complications associated with a premature infant are also possible.

Race

Placental abruption is more common in African American women than in either white or Latin American women. However, whether this is the result of socioeconomic, genetic, or combined factors remains unclear.

Sex

This condition is observed only in pregnancy.

Age

An increased risk of placental abruption has been demonstrated in patients younger than 20 years and those older than 35 years.

Clinical

History

Symptoms may include vaginal bleeding, contractions, abdominal tenderness, and decreased fetal movement. Eliciting any history of trauma, such as assault, abuse, or motor vehicle accident, is important. A quick review of the patient's prenatal course, such as a known history of placenta previa, may help lead to the correct diagnosis. The patient should also be asked if she has had a placental abruption in a previous pregnancy. Questioning the patient about cocaine abuse, hypertension, trauma, or tobacco abuse is also crucial.

  • Vaginal bleeding
    • Vaginal bleeding is present in 80% of patients diagnosed with placental abruptions.
    • Bleeding may be significant enough to jeopardize both fetal and maternal health in a relatively short period.
    • Remember that 20% of abruptions are associated with a concealed hemorrhage and the absence of vaginal bleeding does not exclude a diagnosis of abruptio placentae.
  • Contractions/uterine tenderness
    • Contractions and uterine hypertonus are part of the classic triad observed with placental abruption.
    • Uterine activity is a sensitive marker of abruption and, in the absence of vaginal bleeding, should suggest the possibility of an abruption, especially after some form of trauma or in a patient with multiple risk factors.
  • Decreased fetal movement
    • This may be the presenting complaint.
    • Decreased fetal movement may be due to fetal jeopardy or death.

Physical

The physical examination of a patient who is bleeding must be targeted at determining the origin of the hemorrhage. Simultaneously, the patient must be stabilized quickly. With placental abruption, a relatively stable patient may rapidly progress to a state of hypovolemic shock.

  • Vaginal bleeding
    • Bleeding may be profuse and come in "waves" as the patient's uterus contracts.
    • A fluid the color of port wine may be observed when the membranes are ruptured.
  • Contractions/uterine tenderness
    • Uterine contractions are a common finding with placental abruption.
    • Contractions progress as the abruption expands, and uterine hypertonus may be noted.
    • Contractions are painful and palpable.
    • Uterine hyperstimulation may occur with little or no break in uterine activity between contractions.
  • Shock
    • Patients may present with hypovolemic shock, with or without vaginal bleeding, because a concealed hemorrhage may be present.
    • As with any hypovolemic condition, blood pressure drops as the pulse increases, urine output falls, and the patient progresses from an alert to an obtunded state as the condition worsens.
  • Absence of fetal heart sounds: This occurs when the abruption progresses to the point that the fetus dies.
  • Signs of possible fetal jeopardy
    • Fetal bradycardia is prolonged.
    • Repetitive, late decelerations are present.
    • Short-term variability is decreased.
  • Fundal height: This may increase rapidly because of an expanding intrauterine hematoma.
  • Important note: Do not perform a digital examination on a pregnant patient with vaginal bleeding without first ascertaining the location of the placenta. Before a pelvic examination can be safely performed, an ultrasonographic examination should be performed to exclude placenta previa. If placenta previa is present, a pelvic examination, either with a speculum or with bimanual examination, may initiate profuse bleeding.

Causes

While multiple risk factors are associated with abruptio placentae, only a few events have been closely linked to this condition, including the following:

  • Cigarette smoking/tobacco abuse
    • Cigarette smoking increases a patient's overall risk of placental abruption.
    • A prospective cohort study showed the risk of abruption to be increased by 40% for each year of smoking prior to pregnancy.
    • In addition to the increased risk of abruption caused by tobacco abuse, the perinatal mortality rate of infants born to women who smoke and have an abruption is increased.
  • Cocaine (powder or crack) abuse
    • The hypertension and increased levels of catecholamines caused by cocaine abuse are thought to be responsible for a vasospasm in the uterine blood vessels that causes placental separation and abruption. However, this hypothesis has not been definitively proven.
    • The rate of abruption in patients who abuse cocaine has been reported to be approximately 13-35% and may be dose-dependent.
  • Trauma
    • Abdominal trauma is a major risk factor for placental abruption.
    • Motor vehicle accidents often cause abdominal trauma. The lower seat belt should extend across the pelvis, not across the mid abdomen, where the fetus is located.
    • Trauma may also be due to domestic abuse or assault, both of which are underreported.
  • Thrombophilia
    • Some literature supports the association of specific thrombophilias, such as factor V Leiden mutation, prothrombin gene mutation (A20210 mutation), hyperhomocysteinemia, activated protein C resistance, antithrombin III deficiency, and anticardiolipin immunoglobulin G antibodies, and this risk may be independent of the presence of preeclampsia. The presence of a thrombophilia may also influence the severity of the abruption.
    • Note, however, that other literature does not support an association between thrombophilias and placental abruption. If a patient with a placental abruption is screened and is positive for a thrombophilia she should be offered treatment with heparin and aspirin during the next pregnancy.
  • Other notable risk factors include the following:
    • Previous placental abruption
    • Chorioamnionitis
    • Prolonged rupture of membranes (24 h or longer)
    • Preeclampsia
    • Hypertension
    • Maternal age of 35 years or older
    • Male fetal sex
    • Low socioeconomic status
    • Elevated second trimester maternal serum alpha-fetoprotein (associated with up to a 10-fold increased risk of abruption)

More on Abruptio Placentae

Overview: Abruptio Placentae
Differential Diagnoses & Workup: Abruptio Placentae
Treatment & Medication: Abruptio Placentae
Follow-up: Abruptio Placentae
Multimedia: Abruptio Placentae
References

References

  1. Abu-Heija A, al-Chalabi H, el-Iloubani N. Abruptio placentae: risk factors and perinatal outcome. J Obstet Gynaecol Res. Apr 1998;24(2):141-4. [Medline].

  2. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol. Feb 10 2002;101(1):6-14. [Medline].

  3. American College of Obstetricians and Gynecologists. ACOG technical bulletin. Preterm labor. Number 206--June 1995 (Replaces No. 133, October 1989). Int J Gynaecol Obstet. Sep 1995;50(3):303-13. [Medline].

  4. Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. Apr 1999;93(4):622-8. [Medline].

  5. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. Feb 15 2001;153(4):332-7. [Medline].

  6. Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol. Nov 1 1996;144(9):881-9. [Medline].

  7. Ananth CV, Savitz DA, Bowes WA Jr, Luther ER. Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. Br J Obstet Gynaecol. May 1997;104(5):572-8. [Medline].

  8. Anteby EY, Musalam B, Milwidsky A, et al. Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption. Eur J Obstet Gynecol Reprod Biol. Mar 15 2004;113(1):31-5. [Medline].

  9. Clark SL. Placentae previa and abruptio placentae. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine. 5th ed. Philadelphia, Pa: WB Saunders; 2004:715.

  10. Facchinetti F, Marozio L, Grandone E, et al. Thrombophilic mutations are a main risk factor for placental abruption. Haematologica. Jul 2003;88(7):785-8. [Medline].

  11. Foley MR, Strong TH Jr, Foley MR, eds. Placental Abruption. In: Obstetric Intensive Care: A practical manual. First ed. Philadelphia, Pa: WB Saunders; 1997:35-9.

  12. Gabbe SG, Niebyl JR, Simpson JL, eds. Abruptio placenta. In: Obstetrics - Normal and Problem Pregnancies. 3rd ed. New York, NY: Churchill Livingstone; 1996:505-10.

  13. Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. Aug 2002;21(8):837-40. [Medline].

  14. Hoskins IA, Friedman DM, Frieden FJ. Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption. Obstet Gynecol. Aug 1991;78(2):279-82. [Medline].

  15. Kramer MS, Usher RH, Pollack R. Etiologic determinants of abruptio placentae. Obstet Gynecol. Feb 1997;89(2):221-6. [Medline].

  16. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol. Aug 2004;191(2):412-24. [Medline].

  17. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. Jan 7 1999;340(1):9-13. [Medline].

  18. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol. Feb 2002;99(2):333-41. [Medline].

  19. Misra DP, Ananth CV. Risk factor profiles of placental abruption in first and second pregnancies: heterogeneous etiologies. J Clin Epidemiol. May 1999;52(5):453-61. [Medline].

  20. No authors listed. Correction: Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy. N Engl J Med. Jul 29 1999;341(5):384. [Medline].

  21. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. Oct 2006;108(4):1005-16.

  22. Pritchard JA, Mason R, Corley M, Pritchard S. Genesis of severe placental abruption. Am J Obstet Gynecol. Sep 1 1970;108(1):22-7. [Medline].

  23. Pritchard JA, Cunningham FG, Pritchard SA, Mason RA. On reducing the frequency of severe abruptio placentae. Am J Obstet Gynecol. Nov 1991;165(5 Pt 1):1345-51. [Medline].

  24. Rana A, Sawhney H, Gopalan S. Abruptio placentae and chorioamnionitis-microbiological and histologic correlation. Acta Obstet Gynecol Scand. May 1999;78(5):363-6. [Medline].

  25. Rasmussen S, Irgens LM, Bergsjo P. The occurrence of placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand. Mar 1996;75(3):222-8. [Medline].

  26. Raymond EG, Mills JL. Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand. Nov 1993;72(8):633-9. [Medline].

Further Reading

Keywords

abruptio placentae, placental abruption, fetal death, maternal mortality, fetal mortality, pregnancy, parturition, pregnancy complication, cesarean delivery, cesarean section, caesarean delivery, caesarean section, c-section, C-section, c section, C section, prematurity, premature infant, Couvelaire uterus

Contributor Information and Disclosures

Author

Shad H Deering, MD, Clinical Assistant Professor, Department of Obstetrics and Gynecology, University of Washington; Medical Director, Andersen Simulation Center, Madigan Army Medical Center
Shad H Deering, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of Professors of Gynecology and Obstetrics, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

Medical Editor

Bruce A Meyer, MD, MBA, Vice President for Medical Affairs, Associate Dean for Health System Affairs and Director of the Faculty Practice Plan, Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical School
Bruce A Meyer, MD, MBA is a member of the following medical societies: American College of Obstetricians and Gynecologists, American College of Physician Executives, American Institute of Ultrasound in Medicine, Association of Professors of Gynecology and Obstetrics, Massachusetts Medical Society, Medical Group Management Association, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Antonio V Sison, MD, Medical Director, Ob/Gyn Group, Robert Wood Johnson University Hospital at Hamilton
Antonio V Sison, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists and Association of Professors of Gynecology and Obstetrics
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Carl V Smith, MD, The Distinguished Chris J and Marie A Olson Chair of Obstetrics and Gynecology, Professor, Department of Obstetrics and Gynecology, University of Nebraska Medical Center
Carl V Smith, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Arkansas Medical Society, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Council of University Chairs of Obstetrics and Gynecology, Nebraska Medical Association, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.